AIDS Healthcare Foundation

The AIDS Healthcare Foundation (AHF) is a global non-profit organization providing cutting-edge medicine and advocacy to more than 665,000 people in 36 countries. AHF is the largest provider of HIV/AIDS medical care in the U.S. Since 1987, AHF has cared for thousands of people living with HIV and AIDS worldwide, testing up to 1 billion people each year and creating and implementing new programs in communities across the U.S and abroad.

Mission and Vision
AHF funds its mission to rid the world of AIDS through a network of pharmacies, thrift stores, healthcare contracts and other strategic partnerships. Generating new, innovative ways of treatment, prevention and advocacy has been the hallmark of their success. AHF currently is leading a mass testing initiative to identify and treat the 25 million people who are unaware they are infected.

Patient Population of Focus (PoF) in Florida

  • Total number of high risk patients: 7,000
  • Number of high-risk patients not at goal (the gap): 2,100
  • Percent of high risk patients at goal: 70%
  • Current number of high-risk patients receiving CMM services: >4,000

AIMM Inclusion Criteria
HIV/AIDS patients that suffer from four chronic health conditions: HIV/AIDS, diabetes, dyslipidemia, and hypertension.

Goals When Joining AIMM

  • Close the gap, i.e., the number of high-risk patients that are not at clinical goal.
  • Improve adherence, identify and resolve MRPs, and bring more than 50% of high-risk patients under control.
  • Increase patients with an undetectable viral load to more than 90%.
  • Continue to engage insurers to invest in their expertise to provide impactful clinical pharmacy programs, touchpoints and services to improve patient health outcomes, and to potentially reduce total healthcare costs, as we impact medication adherence, medication safety, and disease state management.


  • In the population of focus, 70% of high risk patients are at goal.
  • All 39 pharmacy locations in Florida provide focused MTM and adherence programs for at-risk patients.
  • Commitment from senior leaders to develop Integrated Medication Management as a “value-added” service for all 7,000 HIV/AIDS patients.
  • Creation of 2 Full time Clinical Hubs (East Coast and West Coast)
  • Addition of Clinical Pharmacy staff for Integrated Medication Management (5 Clinical Pharmacists and 4 Pharmacy Technicians)
  • Developed medication intervention documentation to identify and prevent MRPs (4041 interventions documented over a 6 month period and 966 MRP reported).


Cheryl Graziose

Brandon Patchett